Biofrontera Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Biofrontera Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $2.35M.
- Biofrontera Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $8.50M.
- Biofrontera Inc. stock issued during period, value, new issues for fiscal 2025 was $10.85M.
- Biofrontera Inc. stock issued during period, value, new issues for fiscal 2022 was $3.68M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $10.85M 10-K · filed 2026-03-19 |
| 2025-09-30 | $8.50M 10-Q · filed 2025-11-12 | |
| 2022-12-31 | $3.68M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $14.94M 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |